Related references
Note: Only part of the references are listed.AZD4573 Is a Highly Selective CDK9 Inhibitor That Suppresses MCL-1 and Induces Apoptosis in Hematologic Cancer Cells
Justin Cidado et al.
CLINICAL CANCER RESEARCH (2020)
Engineered Protein Scaffolds as Next-Generation Therapeutics
Michaela Gebauer et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 60 (2020)
Modulation of virus-induced NF-κB signaling by NEMO coiled coil mimics
Jouliana Sadek et al.
NATURE COMMUNICATIONS (2020)
The Increasingly Human and Profitable Monoclonal Antibody Market
Antonio L. Grilo et al.
TRENDS IN BIOTECHNOLOGY (2019)
Pathophysiology and inhibition of IL-23 signaling in psoriatic arthritis: A molecular insight
Cuong Thach Nguyen et al.
CLINICAL IMMUNOLOGY (2019)
Next-generation characterization of the Cancer Cell Line Encyclopedia
Mahmoud Ghandi et al.
NATURE (2019)
MCL-1 inhibitors ? where are we now (2019)?
Steven Fletcher
EXPERT OPINION ON THERAPEUTIC PATENTS (2019)
Advances in protein structure prediction and design
Brian Kuhlman et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
Bispecific applications of non-immunoglobulin scaffold binders
Sophia Hober et al.
METHODS (2019)
S64315 (MIK665) is a potent and selective Mcl1 inhibitor with strong antitumor activity across a diverse range of hematologic tumor models
Ana Leticia Maragno et al.
CANCER RESEARCH (2019)
Structural Activation of Pro-inflammatory Human Cytokine IL-23 by Cognate IL-23 Receptor Enables Recruitment of the Shared Receptor IL-12Rβ1
Yehudi Bloch et al.
IMMUNITY (2018)
CDK9 inhibitors in acute myeloid leukemia
Silvia Boffo et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Iterative optimization yields Mcl-1-targeting stapled peptides with selective cytotoxicity to Mcl-1-dependent cancer cells
Raheleh Rezaei Araghi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
AMG 176, a Selective MCL1 Inhibitor, Is Effective in Hematologic Cancer Models Alone and in Combination with Established Therapies
Sean Caenepeel et al.
CANCER DISCOVERY (2018)
Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemia
Adriana E. Tron et al.
NATURE COMMUNICATIONS (2018)
From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors
Avi Ashkenazi et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Cell-Penetrating Peptides: From Basic Research to Clinics
Giulia Guidotti et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2017)
Affimers proteins are versatile and renewable affinity reagents
Christian Tiede et al.
ELIFE (2017)
Overview of CDK9 as a target in cancer research
Fatima Morales et al.
CELL CYCLE (2016)
Inactivation of prosurvival Bcl-2 proteins activates Bax/Bak through the outer mitochondrial membrane
Katelyn L. O'Neill et al.
GENES & DEVELOPMENT (2016)
The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models
Andras Kotschy et al.
NATURE (2016)
The coming of age of de novo protein design
Po-Ssu Huang et al.
NATURE (2016)
Improved insights into protein thermal stability: from the molecular to the structurome scale
Fabrizio Pucci et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL AND ENGINEERING SCIENCES (2016)
Resurfaced cell-penetrating nanobodies: A potentially general scaffold for intracellularly targeted protein discovery
Virginia J. Bruce et al.
PROTEIN SCIENCE (2016)
The role of negative selection in protein evolution revealed through the energetics of the native state ensemble
Jordan Hoffmann et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2016)
Structural Basis of Non-Steroidal Anti-Inflammatory Drug Diclofenac Binding to Human Serum Albumin
Yao Zhang et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2015)
Bcl-2 family of proteins as drug targets for cancer chemotherapy: the long way of BH3 mimetics from bench to bedside
Laura Vela et al.
CURRENT OPINION IN PHARMACOLOGY (2015)
Challenges and opportunities for non-antibody scaffold drugs
Rodrigo Vazquez-Lombardi et al.
DRUG DISCOVERY TODAY (2015)
Non-immunoglobulin scaffolds: a focus on their targets
Katja Skrlec et al.
TRENDS IN BIOTECHNOLOGY (2015)
Early Endosomal Escape of a Cyclic Cell-Penetrating Peptide Allows Effective Cytosolic Cargo Delivery
Ziqing Qian et al.
BIOCHEMISTRY (2014)
Recent progress of cell-penetrating peptides as new carriers for intracellular cargo delivery
Feihu Wang et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Intracellular drug concentration and disposition - The missing link?
Michael M. Hann et al.
METHODS (2014)
The use of a neutral peptide aptamer scaffold to anchor BH3 peptides constitutes a viable approach to studying their function
L. K. J. Stadler et al.
CELL DEATH & DISEASE (2014)
Structural basis of IL-23 antagonism by an Alphabody protein scaffold
Johan Desmet et al.
NATURE COMMUNICATIONS (2014)
The PDB_REDO server for macromolecular structure model optimization
Robbie P. Joosten et al.
IUCRJ (2014)
Fifteen Years of Cell-Penetrating Guanidinium-Rich Molecular Transporters: Basic Science, Research Tools, and Clinical Applications
Erika Geihe Stanzl et al.
ACCOUNTS OF CHEMICAL RESEARCH (2013)
Efficient Delivery of Cyclic Peptides into Mammalian Cells with Short Sequence Motifs
Ziqing Qian et al.
ACS CHEMICAL BIOLOGY (2013)
Quantitative assessment of the relative contributions of steric repulsion and chemical interactions to macromolecular crowding
Allen P. Minton
BIOPOLYMERS (2013)
Targeting BCL-2 with the BH3 Mimetic ABT-199 in Estrogen Receptor-Positive Breast Cancer
Francois Vaillant et al.
CANCER CELL (2013)
Seeking a MCL-1 inhibitor
G. Brumatti et al.
CELL DEATH AND DIFFERENTIATION (2013)
Formation of protein complexes in crowded environments - From in vitro to in vivo
Yael Phillip et al.
FEBS LETTERS (2013)
Influence of crowded cellular environments on protein folding, binding, and oligomerization: Biological consequences and potentials of atomistic modeling
Huan-Xiang Zhou
FEBS LETTERS (2013)
Rapid Measurement of Intracellular Unbound Drug Concentrations
Andre Mateus et al.
MOLECULAR PHARMACEUTICS (2013)
Impact of reconstituted cytosol on protein stability
Mohona Sarkar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Chemical Genomics Identifies Small-Molecule MCL1 Repressors and BCL-xL as a Predictor of MCL1 Dependency
Guo Wei et al.
CANCER CELL (2012)
Rational Design of Proteolytically Stable, Cell-Permeable Peptide-Based Selective Mcl-1 Inhibitors
Avinash Muppidi et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
Overview of the CCP4 suite and current developments
Martyn D. Winn et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
A Class of Human Proteins that Deliver Functional Proteins into Mammalian Cells In Vitro and In Vivo
James J. Cronican et al.
CHEMISTRY & BIOLOGY (2011)
Mutation to Bax beyond the BH3 Domain Disrupts Interactions with Pro-survival Proteins and Promotes Apoptosis
Peter E. Czabotar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Phase I Study of Navitoclax (ABT-263), a Novel Bcl-2 Family Inhibitor, in Patients With Small-Cell Lung Cancer and Other Solid Tumors
Leena Gandhi et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
The quantitative proteome of a human cell line
Martin Beck et al.
MOLECULAR SYSTEMS BIOLOGY (2011)
Potent Delivery of Functional Proteins into Mammalian Cells in Vitro and in Vivo Using a Supercharged Protein
James J. Cronican et al.
ACS CHEMICAL BIOLOGY (2010)
Integration, scaling, space-group assignment and post-refinement
Wolfgang Kabsch
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)
Features and development of Coot
P. Emsley et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)
PHENIX: a comprehensive Python-based system for macromolecular structure solution
Paul D. Adams et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2010)
Mcl-1; the molecular regulation of protein function
Luke W. Thomas et al.
FEBS LETTERS (2010)
Apoptotic Regulation by MCL-1 through Heterodimerization
Qian Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Determinants of BH3 Binding Specificity for Mcl-1 versus BcI-xL
Sanjib Dutta et al.
JOURNAL OF MOLECULAR BIOLOGY (2010)
The MCL-1 BH3 helix is an exclusive MCL-1 inhibitor and apoptosis sensitizer
Michelle L. Stewart et al.
NATURE CHEMICAL BIOLOGY (2010)
Mcl-1-Bim complexes accommodate surprising point mutations via minor structural changes
Emiko Fire et al.
PROTEIN SCIENCE (2010)
Recent advances in the use of cell-penetrating peptides for medical and biological applications
Sonali B. Fonseca et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Conformational Changes in Bcl-2 Pro-survival Proteins Determine Their Capacity to Bind Ligands
Erinna F. Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Structure of the BH3 domains from the p53-inducible BH3-only proteins Noxa and Puma in complex with Mcl-1
Catherine L. Day et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
Phaser crystallographic software
Airlie J. McCoy et al.
JOURNAL OF APPLIED CRYSTALLOGRAPHY (2007)
Arginine grafting to endow cell permeability
Stephen M. Fuchs et al.
ACS CHEMICAL BIOLOGY (2007)
Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies
Hyungjin Kim et al.
NATURE CELL BIOLOGY (2006)
Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: The oblimersen melanoma study group
Agop Y. Bedikian et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Solution structure of prosurvival Mcl-1 and characterization of its binding by proapoptotic BH3-only ligands
CL Day et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Inhibition of protein crystallization by evolutionary negative design
JPK Doye et al.
PHYSICAL BIOLOGY (2004)
Crystal structure and biological implications of a bacterial albumin binding module in complex with human serum albumin
S Lejon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The druggable genome
AL Hopkins et al.
NATURE REVIEWS DRUG DISCOVERY (2002)
Dysregulation of apoptosis genes in hematopoietic malignancies
S Kitada et al.
ONCOGENE (2002)
Histone deacetylase inhibitor downregulation of bcl-xl gene expression leads to apoptotic cell death in mesothelioma
XBX Cao et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2001)
BCL-2, BCL-XL sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis
EHYA Cheng et al.
MOLECULAR CELL (2001)
Share Paper
